Immix Biopharma Investor Presentation Deck

N-GENIUS Technology Platform - Proprietary EXPAND technology and COBRA Binding Domain Are Differentiated Innovations Abecma 4-11 CD32 Carvykti 4-1BB CD3( Note: Graphic representation. COBRA = Codon Optimized Binder for Receptor Antigens - Proprietary Binding Domain CART- ddBCMA 4-1BB CD3( NXC-201 with COBRA Binding Domain 4-1BBY CD3CY N-GENIUS EXPAND Technology ●●● IMMIX do BIOPHARMA 16

View entire presentation